NCT07389161 Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
| NCT ID | NCT07389161 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Mb Crohn |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2026-04-28 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2026-04-28 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of the study are 1. to determine the effect on dysbiosis, permeability and inflammatory activity after administration of a Mediterranean like diet (a Nordic equivalent, "Nordiet"), 2. to investigate life style related factors, such as exercise, psychosexual health and quality of life and their relation to the disease activity.
Eligibility Criteria
Inclusion Criteria: * IBD, i.e., Mb Crohn or ulcerrative colitis * Moderatively active disease (calprotectin 200-600) Exclusion Criteria: * Proctitis alone * Inactive disease * Severe flare up requiring in-patient care * Planned change of treatment * Antibiotic treatment during the last month * Pregnancy * Inability to understand Swedish * Multimorbidity
Contact & Investigator
Vedrana Vejzovic, Associate professor
STUDY DIRECTOR
Malmö University
Frequently Asked Questions
Who can join the NCT07389161 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Mb Crohn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07389161 currently recruiting?
Yes, NCT07389161 is actively recruiting participants. Contact the research team at klas.sjoberg@med.lu.se for enrollment information.
Where is the NCT07389161 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT07389161 clinical trial?
NCT07389161 is sponsored by Region Skane. The principal investigator is Vedrana Vejzovic, Associate professor at Malmö University. The trial plans to enroll 160 participants.